ANNA ELLIS: Open Payments
NPI 1285032482 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,314 in 110 payments from 18 companies in 2025. Trend: 2023 $1,405 · 2024 $2,083 · 2025 $3,314
Food & beverage: $3,104Education: $210
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $531 |
| ABBVIE INC. | 20 | $406 |
| Janssen Biotech, Inc. | 11 | $345 |
| UCB, Inc. | 11 | $329 |
| Amgen Inc. | 8 | $303 |
| LEO Pharma Inc. | 8 | $249 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $180 |
| Novartis Pharmaceuticals Corporation | 6 | $168 |
| Lilly USA, LLC | 9 | $157 |
| Incyte Corporation | 2 | $153 |
Products named: DUPIXENT, TREMFYA, Bimzelx, Otezla, SKYRIZI, RINVOQ, ANZUPGO, TALTZ.
Industry payments across NV — which companies pay providers there.
